学术探索
学术期刊
新闻热点
数据分析
智能评审

Immunotherapy: past, present and future

被引：437
作者：
Waldmann, TA [1 ]
机构：
[1] NCI, Metab Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA
来源：
NATURE MEDICINE | 2003年 / 9卷 / 03期
基金：
美国国家卫生研究院;
关键词：
D O I：
10.1038/nm0303-269
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Harnessing the immune system to treat chronic infectious diseases or cancer is a major goal of immunotherapy. Among others, impediments to this aim include host failure to identify tumor antigens, tolerance to self and negative immunoregulatory mechanisms. But with recent progress, active and passive immunotherapy are proving themselves as effective therapeutic strategies.
引用
收藏
页码：269 / 277
页数：9
相关论文
共 70 条
  • [41] Parkhurst MR, 1996, J IMMUNOL, V157, P2539
  • [42] PHASE-II TRIAL OF I-131 B1 (ANTI-CD20) ANTIBODY THERAPY WITH AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR RELAPSED B-CELL LYMPHOMAS
    PRESS, OW
    EARY, JF
    APPELBAUM, FR
    MARTIN, PJ
    NELP, WB
    GLENN, S
    FISHER, DR
    PORTER, B
    MATTHEWS, DC
    GOOLEY, T
    BERNSTEIN, ID
    [J]. LANCET, 1995, 346 (8971) : 336 - 340
  • [43] A comparative evaluation of conventional and pretargeted radioimmunotherapy of CD20-expressing lymphoma xenografts
    Press, OW
    Corcoran, M
    Subbiah, K
    Hamlin, DK
    Wilbur, DS
    Johnson, T
    Theodore, L
    Yau, E
    Mallett, R
    Meyer, DL
    Axworthy, D
    [J]. BLOOD, 2001, 98 (08) : 2535 - 2543
  • [44] A HUMANIZED ANTIBODY THAT BINDS TO THE INTERLEUKIN-2 RECEPTOR
    QUEEN, C
    SCHNEIDER, WP
    SELICK, HE
    PAYNE, PW
    LANDOLFI, NF
    DUNCAN, JF
    AVDALOVIC, NM
    LEVITT, M
    JUNGHANS, RP
    WALDMANN, TA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (24) : 10029 - 10033
  • [45] The prime-boost strategy: exciting prospects for improved vaccination
    Ramshaw, IA
    Ramsay, AJ
    [J]. IMMUNOLOGY TODAY, 2000, 21 (04): : 163 - 165
  • [46] ROBBINS PF, 1996, CURR OPIN IMMUNOL, V8, P626
  • [47] A new era for cancer immunotherapy based on the genes that encode cancer antigens
    Rosenberg, SA
    [J]. IMMUNITY, 1999, 10 (03) : 281 - 287
  • [48] TREATMENT OF 283 CONSECUTIVE PATIENTS WITH METASTATIC MELANOMA OR RENAL-CELL CANCER USING HIGH-DOSE BOLUS INTERLEUKIN-2
    ROSENBERG, SA
    YANG, JC
    TOPALIAN, SL
    SCHWARTZENTRUBER, DJ
    WEBER, JS
    PARKINSON, DR
    SEIPP, CA
    EINHORN, JH
    WHITE, DE
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (12): : 907 - 913
  • [49] ROSENBERG SA, 1996, J IMMUNOTHER, V19, P8
  • [50] HUMAN NEOPLASMS ELICIT MULTIPLE SPECIFIC IMMUNE-RESPONSES IN THE AUTOLOGOUS HOST
    SAHIN, U
    TURECI, O
    SCHMITT, H
    COCHLOVIUS, B
    JOHANNES, T
    SCHMITS, R
    STENNER, F
    LUO, GR
    SCHOBERT, I
    PFREUNDSCHUH, M
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (25) : 11810 - 11813
1234567